There is a solution for these patients: longer, more frequent dialysis. Using the assets of our organization, CVS Health plans to make this solution a reality. Most dialysis patients receive treatment three times a week for, on average, three-and-a-half hours at a time. By enabling longer, more frequent dialysis, we hope to improve outcomes, including patient satisfaction, and help patients to live a more normal life, while also significantly reducing overall health care costs for these patients. We will also utilize our clinical assets to help patients get diagnosed earlier, before the need for urgent dialysis, educate them about their treatment options, and provide comorbidity and nutritional counseling, and help them make a safe transition to home dialysis, when needed. We are in a position to make the right investments to change how and where patients receive care – bring care to them – and help improve outcomes. Our integrated pharmacy model, clinical expertise, and high-touch care can also help payors better manage costs.
View more 2018 Forum highlights here.
The home hemodialysis device under development has not received market clearance from the FDA. The device will be studied in a clinical trial conducted by CVS Health.
©2018 CVS Health and/or one of its affiliates: Confidential and Proprietary. Do not copy or distribute without written permission.